系统性白介素-6水平与年龄相关性黄斑变性继发地图样萎缩进展速率相关
该前瞻性研究纳入42例地图样萎缩(GA)患者、41例新生血管性AMD患者和27例健康对照,检测血浆慢性炎症标志物。GA患者IL-6、TNF受体2和CRP较健康对照升高,且血浆IL-6与GA病变扩大速率呈中度显著相关(R2=0.23,P=0.0035)。
要点
- GA患者血浆IL-6、TNF受体2和CRP较健康对照显著升高。
- GA患者IL-8水平显著高于新生血管性AMD患者。
- 血浆IL-6与GA扩大速率相关(R2=0.23,P=0.0035),或为疾病活动性生物标志物。
核心结论
- 慢性炎症标志物与AMD继发GA的存在强相关。
- 血浆IL-6具备预测GA进展的能力,是首个已知的GA疾病活动性血浆生物标志物。
研究设计与样本
- 前瞻性纳入42例GA患者、41例新生血管性AMD患者和27例健康对照。
- 量化血浆IL-1β、IL-6、IL-8、TNF受体2和CRP水平,并采用炎症汇总评分聚类慢性炎症标志物。
- 通过基线和1年后的眼底自发荧光图像测量萎缩病变扩大速率,36例GA患者完成随访。
主要发现
- GA患者IL-6(P=0.009)、TNF受体2(P=0.013)和CRP(P=0.017)较健康对照升高。
- GA患者IL-8水平显著高于新生血管性AMD患者(P=0.013)。
- 炎症汇总评分在新生血管性AMD患者中较高(P=0.024),在GA患者中更高(<0.001),均相较健康对照。
- 血浆IL-6与GA扩大速率呈中度显著相关(R2=0.23,P=0.0035)。
关键数值与推荐
- GA患者IL-6较健康对照升高,P=0.009。
- GA患者TNF受体2较健康对照升高,P=0.013。
- GA患者CRP较健康对照升高,P=0.017。
- GA患者IL-8较新生血管性AMD患者升高,P=0.013。
- 血浆IL-6与GA扩大速率相关,R2=0.23,P=0.0035。
临床怎么用
- 血浆IL-6或可作为评估GA疾病活动性和进展风险的生物标志物。
- 慢性炎症在GA病理中起重要作用,支持抗炎治疗策略的探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Geographic atrophy (GA) is a clinical phenotype of late age-related macular degeneration (AMD) with no current treatment available. In this study, we investigated markers of chronic inflammation in plasma of patients with GA and how these relate to progression rate. METHODS: We prospectively included 42 patients with GA, 41 patients with neovascular AMD, and 27 healthy controls. We quantified levels of interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor (TNF) receptor 2, and C-reactive protein (CRP). We adapted an inflammation summary score to cluster conceptually related markers of chronic inflammation. Enlargement rate of the atrophic lesion was measured from fundus autofluorescence images performed at baseline and after 1 year. RESULTS: Patients with GA showed an increase in proinflammatory markers of IL-6 (P = 0.009), TNF receptor 2 (P = 0.013), and CRP (P = 0.017) compared to healthy controls. We found that IL-8 levels were markedly higher in patients with GA when compared to patients with neovascular AMD (P = 0.013). The inflammation summary score was high in patients with neovascular AMD (P = 0.024), but even higher in patients with GA (<0.001), when compared to healthy controls. GA enlargement was measured in 36 patients, who completed follow-up. Plasma levels of IL-6 had a moderate but significant correlation with GA enlargement rate (R2 = 0.23, P = 0.0035). CONCLUSIONS: Markers of chronic inflammation strongly associates with presence of GA secondary to AMD. Plasma IL-6 possesses predictive ability of progression and constitutes the first known plasma biomarker of disease activity in GA. These findings shed light into a poorly understood clinical phenotype of AMD and highlights the important role of chronic inflammation in GA.
引用
- Krogh Nielsen M, Subhi Y, Molbech CR, et al. Systemic Levels of Interleukin-6 Correlate With Progression Rate of Geographic Atrophy Secondary to Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2019. PMID: 30644965. doi:10.1167/iovs.18-25878
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。